Hilltop Holdings Inc. Boosts Stock Position in Amgen Inc. $AMGN

robot
Abstract generation in progress

Hilltop Holdings Inc. significantly increased its stake in Amgen Inc. by 715.8% in the third quarter, now owning 29,524 shares valued at $8.33 million. Amgen also reported strong quarterly earnings, beating analyst expectations with $5.29 EPS and $9.87 billion in revenue, and declared a quarterly dividend of $2.52 per share. Analyst sentiment for Amgen remains mixed, with a consensus price target of $354.00, despite some recent downgrades and upgrades.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments